Tardive Dyskinesia Across Psychiatric Disorders

Roger McIntyre, MD, FRCPC, and Joseph Goldberg, MD, discuss mood disorders, antipsychotics and tardive dyskinesia (TD).

Joseph F. Goldberg, MD Roger McIntyre, MD, FRCPC Released: May 24, 2021

Leslie Citrome, MD, MPH, and Joseph P. McEvoy, MD, discuss diagnosis of tardive dyskinesia (TD) in clinical practice.

Leslie Citrome, MD, MPH Joseph P. McEvoy, MD Released: June 11, 2021

John M. Kane, MD, and Rebecca S. Roma, MD, discuss the relationship of extrapyramidal symptoms, antiparkinsonian drugs, and tardive dyskinesia.

John M. Kane, MD Rebecca S. Roma, MD Released: July 20, 2021

In this episode, Greg Mattingly, MD, and W. Clay Jackson, MD, DipTh , discuss how the use of antipsychotics has changed in primary care patients, how primary care physicians can screen for tardive dyskinesia (TD), and increasing needs for the primary care physician in mental health.

W. Clay Jackson, MD, DipTh Greg W. Mattingly, MD Released: August 20, 2021

Greg Mattingly, MD, and W. Clay Jackson, MD, DipTh, discuss a multidisciplinary approach to the evaluation and treatment of patients with tardive dyskinesia.

W. Clay Jackson, MD, DipTh Greg W. Mattingly, MD Released: November 16, 2021

Diana Perkins, MD, MPH, and Martha Sajatovic, MD, discuss the functional and social impact of tardive dyskinesia on the lives of patients.

Diana O. Perkins, MD, MPH Martha Sajatovic, MD Released: January 11, 2022